{"title":"沙特阿拉伯香烟、水烟和电子烟长期使用者的呼吸、血液学和炎症特征的比较评估","authors":"Mazen M Homoud, Rowaida Qoutah, Gokul Krishna, Noran Harbli, Layan Saaty, Afrah Obaidan, Abdulrahman Alkhathami, Noran Jamil, Tala M Alkayyat, Maryam Alsughayyir, Nada Gubari, Saleh Alkhathami, Ali Alqarni, Omar Alqurashi, Khalid Assiri, Khalid Saeed Alwadeai, Wafaa Abdulrahman, Husam Alahmadi, Ayedh Alahmari","doi":"10.18332/tid/202350","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Globally, over 1 billion people smoke, resulting in approximately 8 million deaths each year. Although the health risks associated with traditional cigarettes are extensively documented, there is an increasing need to evaluate the long-term effects of alternative tobacco products, particularly shisha, and e-cigarettes. This study seeks to compare the respiratory, hematological, and inflammatory profiles of long-term users of cigarettes, shisha, and e-cigarettes in Saudi Arabia.</p><p><strong>Methods: </strong>A cross-sectional, observational study was conducted at the Respiratory Therapy laboratories of Batterjee Medical College (BMC), Jeddah, Saudi Arabia, between February 2022 and August 2023. It involved four groups: cigarette smokers, shisha smokers, e-cigarette users, and non-smokers. Pulmonary function tests (PFTs) measured FEV<sub>1</sub>, FVC, and other lung function parameters. Hematological profiles, including WBC, neutrophils, lymphocytes, monocytes, and C-reactive protein (CRP) levels, were assessed.</p><p><strong>Results: </strong>Cigarette and shisha users demonstrated significantly reduced FEV<sub>1</sub> (cigarettes: 3.11 ± 0.54 L/s, shisha: 3.26 ± 0.71 L/s; p≤0.0001), FEV<sub>1</sub> (% predicted: 81.63 ± 12.11 for cigarettes, 88.09 ± 12.92 for shisha; p≤0.0001), and FVC (3.87 ± 0.68 L for cigarettes, 3.95 ± 0.880 L for shisha; p=0.004), compared to non-smokers and e-cigarette users. Cigarette smokers exhibited significantly elevated WBC (7.92 ± 2.84 ×10<sup>9</sup>/L; p≤0.001), neutrophil (4.03 ± 2.29 ×10<sup>9</sup>/L), lymphocyte (2.95 ± 0.95 ×10<sup>9</sup>/L), and monocyte counts (0.67 ± 0.21 ×10<sup>9</sup>/L) compared to non-smokers, shisha, and e-cigarette users (p≤0.0001). Cigarette smokers and shisha smokers presented different lung function results but similar inflammatory profiles. However, e-cigarette users demonstrated comparatively higher lung function and lower inflammatory markers compared to both cigarette and shisha users.</p><p><strong>Conclusions: </strong>Compared to non-smokers, long-term cigarette and shisha smoking is associated with airway obstructive changes and increased inflammatory responses. Although e-cigarette users demonstrated lower inflammatory markers and less deviation from normal PFT, some exhibited borderline values with airway obstruction. Further research is needed to clarify the long-term health consequences of e-cigarette use.</p>","PeriodicalId":23202,"journal":{"name":"Tobacco Induced Diseases","volume":"23 ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12065132/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comparative assessment of respiratory, hematological and inflammatory profiles of long-term users of cigarettes, shisha, and e-cigarettes in Saudi Arabia.\",\"authors\":\"Mazen M Homoud, Rowaida Qoutah, Gokul Krishna, Noran Harbli, Layan Saaty, Afrah Obaidan, Abdulrahman Alkhathami, Noran Jamil, Tala M Alkayyat, Maryam Alsughayyir, Nada Gubari, Saleh Alkhathami, Ali Alqarni, Omar Alqurashi, Khalid Assiri, Khalid Saeed Alwadeai, Wafaa Abdulrahman, Husam Alahmadi, Ayedh Alahmari\",\"doi\":\"10.18332/tid/202350\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Globally, over 1 billion people smoke, resulting in approximately 8 million deaths each year. Although the health risks associated with traditional cigarettes are extensively documented, there is an increasing need to evaluate the long-term effects of alternative tobacco products, particularly shisha, and e-cigarettes. This study seeks to compare the respiratory, hematological, and inflammatory profiles of long-term users of cigarettes, shisha, and e-cigarettes in Saudi Arabia.</p><p><strong>Methods: </strong>A cross-sectional, observational study was conducted at the Respiratory Therapy laboratories of Batterjee Medical College (BMC), Jeddah, Saudi Arabia, between February 2022 and August 2023. It involved four groups: cigarette smokers, shisha smokers, e-cigarette users, and non-smokers. Pulmonary function tests (PFTs) measured FEV<sub>1</sub>, FVC, and other lung function parameters. Hematological profiles, including WBC, neutrophils, lymphocytes, monocytes, and C-reactive protein (CRP) levels, were assessed.</p><p><strong>Results: </strong>Cigarette and shisha users demonstrated significantly reduced FEV<sub>1</sub> (cigarettes: 3.11 ± 0.54 L/s, shisha: 3.26 ± 0.71 L/s; p≤0.0001), FEV<sub>1</sub> (% predicted: 81.63 ± 12.11 for cigarettes, 88.09 ± 12.92 for shisha; p≤0.0001), and FVC (3.87 ± 0.68 L for cigarettes, 3.95 ± 0.880 L for shisha; p=0.004), compared to non-smokers and e-cigarette users. Cigarette smokers exhibited significantly elevated WBC (7.92 ± 2.84 ×10<sup>9</sup>/L; p≤0.001), neutrophil (4.03 ± 2.29 ×10<sup>9</sup>/L), lymphocyte (2.95 ± 0.95 ×10<sup>9</sup>/L), and monocyte counts (0.67 ± 0.21 ×10<sup>9</sup>/L) compared to non-smokers, shisha, and e-cigarette users (p≤0.0001). Cigarette smokers and shisha smokers presented different lung function results but similar inflammatory profiles. However, e-cigarette users demonstrated comparatively higher lung function and lower inflammatory markers compared to both cigarette and shisha users.</p><p><strong>Conclusions: </strong>Compared to non-smokers, long-term cigarette and shisha smoking is associated with airway obstructive changes and increased inflammatory responses. Although e-cigarette users demonstrated lower inflammatory markers and less deviation from normal PFT, some exhibited borderline values with airway obstruction. Further research is needed to clarify the long-term health consequences of e-cigarette use.</p>\",\"PeriodicalId\":23202,\"journal\":{\"name\":\"Tobacco Induced Diseases\",\"volume\":\"23 \",\"pages\":\"\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-05-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12065132/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Tobacco Induced Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.18332/tid/202350\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tobacco Induced Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18332/tid/202350","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
Comparative assessment of respiratory, hematological and inflammatory profiles of long-term users of cigarettes, shisha, and e-cigarettes in Saudi Arabia.
Introduction: Globally, over 1 billion people smoke, resulting in approximately 8 million deaths each year. Although the health risks associated with traditional cigarettes are extensively documented, there is an increasing need to evaluate the long-term effects of alternative tobacco products, particularly shisha, and e-cigarettes. This study seeks to compare the respiratory, hematological, and inflammatory profiles of long-term users of cigarettes, shisha, and e-cigarettes in Saudi Arabia.
Methods: A cross-sectional, observational study was conducted at the Respiratory Therapy laboratories of Batterjee Medical College (BMC), Jeddah, Saudi Arabia, between February 2022 and August 2023. It involved four groups: cigarette smokers, shisha smokers, e-cigarette users, and non-smokers. Pulmonary function tests (PFTs) measured FEV1, FVC, and other lung function parameters. Hematological profiles, including WBC, neutrophils, lymphocytes, monocytes, and C-reactive protein (CRP) levels, were assessed.
Results: Cigarette and shisha users demonstrated significantly reduced FEV1 (cigarettes: 3.11 ± 0.54 L/s, shisha: 3.26 ± 0.71 L/s; p≤0.0001), FEV1 (% predicted: 81.63 ± 12.11 for cigarettes, 88.09 ± 12.92 for shisha; p≤0.0001), and FVC (3.87 ± 0.68 L for cigarettes, 3.95 ± 0.880 L for shisha; p=0.004), compared to non-smokers and e-cigarette users. Cigarette smokers exhibited significantly elevated WBC (7.92 ± 2.84 ×109/L; p≤0.001), neutrophil (4.03 ± 2.29 ×109/L), lymphocyte (2.95 ± 0.95 ×109/L), and monocyte counts (0.67 ± 0.21 ×109/L) compared to non-smokers, shisha, and e-cigarette users (p≤0.0001). Cigarette smokers and shisha smokers presented different lung function results but similar inflammatory profiles. However, e-cigarette users demonstrated comparatively higher lung function and lower inflammatory markers compared to both cigarette and shisha users.
Conclusions: Compared to non-smokers, long-term cigarette and shisha smoking is associated with airway obstructive changes and increased inflammatory responses. Although e-cigarette users demonstrated lower inflammatory markers and less deviation from normal PFT, some exhibited borderline values with airway obstruction. Further research is needed to clarify the long-term health consequences of e-cigarette use.
期刊介绍:
Tobacco Induced Diseases encompasses all aspects of research related to the prevention and control of tobacco use at a global level. Preventing diseases attributable to tobacco is only one aspect of the journal, whose overall scope is to provide a forum for the publication of research articles that can contribute to reducing the burden of tobacco induced diseases globally. To address this epidemic we believe that there must be an avenue for the publication of research/policy activities on tobacco control initiatives that may be very important at a regional and national level. This approach provides a very important "hands on" service to the tobacco control community at a global scale - as common problems have common solutions. Hence, we see ourselves as "connectors" within this global community.
The journal hence encourages the submission of articles from all medical, biological and psychosocial disciplines, ranging from medical and dental clinicians, through health professionals to basic biomedical and clinical scientists.